{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:51:52Z","timestamp":1786978312741,"version":"build-2736575974"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nut in Clin Prac"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite providing significant benefits, home parenteral nutrition (HPN) can be associated with complications such as infections, intestinal failure\u2013associated liver disease, and metabolic abnormalities. Soybean oil (SO)\u2013based intravenous lipid emulsion (ILE) has been noted to contribute to some of these complications, leading to the development of alternative sources of ILE. Mixed\u2010oil (MO) ILE has recently been approved for use in adults with short\u2010term studies revealing a benefit over SO ILE. Currently there is a paucity of data regarding long\u2010term use in the HPN population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The current study reports our experience with MO ILE in 9 HPN patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 9 patients (3 women and 6 men) with average age of 48.1 \u00b1 15.1 years and a median HPN use of 9.9 years (9.0 months\u201330.7 years) were transitioned from SO ILE to MO ILE as a result of intolerance. The 9 patients tolerated MO ILE well for 140.7 \u00b1 29.7 days. The percentage of calories provided through ILE increased from 7.6 \u00b1 6.5% to 18.4 \u00b1 8.2% (\n                      <jats:italic>P<\/jats:italic>\n                      = .003), whereas the dextrose decreased from 66.9 \u00b1 8.4% to 56.9 \u00b1 5.5% (\n                      <jats:italic>P<\/jats:italic>\n                      = .0007). Although statistical significance was not reached, there was a trend toward improvement in alkaline phosphatase from 138.0 (52\u2013884) to 106 (47\u2013512;\n                      <jats:italic>P<\/jats:italic>\n                      = .09).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MO ILE was well tolerated in this small cohort and led to improvement in the macronutrient composition of HPN while providing a trend toward improvement in liver studies. These results are promising; however, additional randomized control trials are needed to delineate the true benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ncp.10014","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T06:36:36Z","timestamp":1518503796000},"page":"851-857","source":"Crossref","is-referenced-by-count":15,"title":["Long\u2010Term Use of Mixed\u2010Oil Lipid Emulsion in Adult Home Parenteral Nutrition Patients: A Case Series"],"prefix":"10.1002","volume":"33","author":[{"given":"Manpreet S.","family":"Mundi","sequence":"first","affiliation":[{"name":"Division of Endocrinology Diabetes Metabolism and Nutrition Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan T.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Carnell","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Hurt","sequence":"additional","affiliation":[{"name":"Division of Endocrinology Diabetes Metabolism and Nutrition Mayo Clinic  Rochester Minnesota USA"},{"name":"Division of General Internal Medicine Mayo Clinic  Rochester Minnesota USA"},{"name":"Division of Gastroenterology and Hepatology Mayo Clinic  Rochester Minnesota USA"},{"name":"Division of Gastroenterology Hepatology and Nutrition University of Louisville  Louisville Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90321-6"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0884533617718472"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0884533616663635"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115587018"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/014860718901300177"},{"issue":"3","key":"e_1_2_7_7_1","first-page":"155","article-title":"Intravenous intralipid 10% vs. 20%, hyperlipidemia, and increase in lipoprotein X in humans","volume":"8","author":"Tashiro T","year":"1992","journal-title":"Nutrition"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(12)60229-X"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607112450301"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.066"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-7-200004040-00003"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1067\/msy.1999.98925"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2011.11.032"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0884533612462900"},{"issue":"6","key":"e_1_2_7_15_1","first-page":"15","article-title":"SMOFlipid versus intralipid in postoperative ICU patients","volume":"1","author":"Metry AA","year":"2014","journal-title":"Enliven J Anesth Crit Care Med"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e32832e08e0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181de210c"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607110363614"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2012.06.011"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2009.04.001"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0796"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K229"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90486-5"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80064-9"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-010-2578-5"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(76)90085-8"},{"issue":"35","key":"e_1_2_7_27_1","first-page":"1347","article-title":"Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function","volume":"47","author":"Hwang TL","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.5.1171"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113416"},{"key":"e_1_2_7_30_1","first-page":"170","article-title":"Interactions of eicosanoids and cytokines in immune regulation","volume":"20","author":"Lewis RA","year":"1990","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0884533612439896"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115595977"}],"container-title":["Nutrition in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fncp.10014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ncp.10014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:12:04Z","timestamp":1760962324000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1002\/ncp.10014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1002\/ncp.10014"],"URL":"https:\/\/doi.org\/10.1002\/ncp.10014","archive":["Portico"],"relation":{},"ISSN":["0884-5336","1941-2452"],"issn-type":[{"value":"0884-5336","type":"print"},{"value":"1941-2452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]}}}